News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 109–144
- Matches
- 622
- Sources here
- 23
- Companies here
- 11
Search results
Stored financial headlines
Active search
622 matching headlines
Ticker or company: ETEMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Perimeter Solutions Inc (PRM) Stock News Today
This page provides stock news and financial information for Perimeter Solutions Inc (PRM). It includes real-time stock data, an overview of the company's financials, and mentions recent earnings. The article indicates that more news will be added soon.
PRM
main company
Sharemaestro market context
Trend signal active
52 weeks +74.0% · Next-week setup positive 58.6%
Bronstein, Gewirtz & Grossman, LLC Encourages Badger Meter, Inc. (BMI) Investors to Inquire about Securities Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Badger Meter, Inc. (BMI) due to alleged corporate wrongdoing. The firm encourages investors who purchased Badger Meter securities before April 18, 2024, and still hold them, to contact them to assist with the investigation. …
BMI
main company
Sharemaestro market context
Price below Trend Line
52 weeks -30.3%
Tandem Diabetes Care (TNDM) Stock Jumps As Margin Recovery Steals The Spotlight
Tandem Diabetes Care's stock surged 19% after its Q2 earnings report, despite a net loss, due to a significant recovery in gross margin to 57%. Revenue grew 6%, and the net loss narrowed by 60%, with strong performance in international pump shipments and an …
TNDM
main company
Sharemaestro market context
Price above Trend Line
52 weeks +90.4%
Perimeter Solutions (PRM) Q2 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Friday, July 31, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Head of Investor Relations - Seth BarkerChief Executive Officer - Haitham KhouriChief Financial Officer - Kyle Sable TAKEAWAYS Net Sales -- $213.8 million, growing 31% year over year …
PRM
main company
Sharemaestro market context
Trend signal active
52 weeks +74.0% · Next-week setup positive 58.6%
Tandem Diabetes Care, Inc. Stock 12‑Month Price Target Raised to $29.5, Implies 57% Upside
Analysts have raised the average 12-month price target for Tandem Diabetes Care, Inc. (TNDM) stock to $29.5, up from $29.19. This new target suggests a potential upside of approximately 57% from its August 6th closing price. The consensus rating among 22 analysts remains a …
TNDM
main company
Sharemaestro market context
Price above Trend Line
52 weeks +90.4%
Tandem Diabetes Care Announces Second Quarter 2026 Financial Results
Tandem Diabetes Care, Inc. reported strong financial results for Q2 2026, with worldwide sales increasing 6% to $254.6 million and gross margin up 460 basis points to 57%. The company also highlighted strategic achievements, including FDA submissions for Tandem Mobi, expanded global technology solutions, …
TNDM
main company
Sharemaestro market context
Price above Trend Line
52 weeks +90.4%
Tandem Diabetes Care Inc (TNDM) News, Articles, Events & Latest Updates
Tandem Diabetes Care Inc (TNDM) reported Q2 2026 financial results, including a loss and lagging revenue estimates, despite some key metrics showing positive movement. The company announced upcoming conference presentations, product compatibility expansions, and plans to release Q2 results in August 2026. This news …
TNDM
main company
Sharemaestro market context
Price above Trend Line
52 weeks +90.4%
Tandem Diabetes Care, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:TNDM)
Tandem Diabetes Care, Inc. published its Q2 2026 earnings call presentation, reporting an EPS of -$0.31, which beat estimates by $0.01. The company's revenue for the quarter was $254.56M, representing a 5.77% year-over-year increase, though it missed revenue expectations by $510.18K. The slide deck …
TNDM
main company
Sharemaestro market context
Price above Trend Line
52 weeks +90.4%
AMETEK INC/ SEC Filing (Aug 7, 2026)
This article details a Form 144 SEC filing by AMETEK Inc. (AME) on August 7, 2026. The filing indicates a proposed sale of 6,608 shares of common stock with an aggregate market value of $1,678,432.00, acquired through an employee stock option exercise. The transaction …
AME
main company
Sharemaestro market context
Trend signal active
52 weeks +37.1% · Next-week setup positive 55.4%
ETFs Investing in Netease Inc Sponsored ADR Stocks
This article provides a comprehensive list of Exchange Traded Funds (ETFs) that hold Netease Inc Sponsored ADR stocks, sorted by market value. It details various ETFs, their issuers, management styles, expense ratios, assets under management (AUM), and performance metrics like price change and 3-year …
NTES
main company
Sharemaestro market context
Trend signal active
52 weeks -2.8%
Tandem Diabetes Care (NASDAQ:TNDM) Shares Gap Down - What's Next?
Tandem Diabetes Care (NASDAQ:TNDM) shares gapped down but later rose by 13.8%. Analyst ratings are mixed, with a consensus "Hold" and an average price target of $28.77, though Mizuho lowered its target to $20. The company reported an adjusted loss of $0.31 per share, …
TNDM
main company
Sharemaestro market context
Price above Trend Line
52 weeks +90.4%
AMETEK Sets Sept. 30 Payment Date for Its $0.34 Dividend
AMETEK (NYSE: AME) has declared a regular quarterly dividend of $0.34 per share for the third quarter ending September 30, 2026. This dividend is payable on September 30, 2026, to shareholders of record as of September 15, 2026. The company, a global provider of …
AME
main company
Sharemaestro market context
Trend signal active
52 weeks +37.1% · Next-week setup positive 55.4%
AMETEK Declares Quarterly Dividend
AMETEK, Inc. (AME) announced that its Board of Directors has declared a regular quarterly dividend of $0.34 per share for the third quarter, ending September 30, 2026. This dividend is payable on September 30, 2026, to shareholders of record as of September 15, 2026. …
AME
main company
Sharemaestro market context
Trend signal active
52 weeks +37.1% · Next-week setup positive 55.4%
Tandem Diabetes Care (NASDAQ: TNDM) lifts Q2 sales to $254.6M, trims loss
Tandem Diabetes Care reported strong second-quarter 2026 results, with worldwide sales increasing by 6% to $254.6 million and a significant improvement in gross margin to 57%. The company also narrowed its GAAP net loss to $21.2 million and achieved positive Adjusted EBITDA of $6.4 …
TNDM
main company
Sharemaestro market context
Price above Trend Line
52 weeks +90.4%
TANDEM DIABETES CARE INC 2026: Revenue $254.56M, EPS ($0.31) — 10-Q Summary
Tandem Diabetes Care Inc. (TNDM) reported its 2026 quarterly results, showing revenue of $254.56 million, an increase from $240.68 million in the previous year. The company significantly reduced its net loss to ($21.17 million) from ($52.4 million) year-over-year, with diluted loss per share narrowing …
TNDM
main company
Sharemaestro market context
Price above Trend Line
52 weeks +90.4%
Tandem Diabetes Q2 2026 slides: PayGo model drives margin expansion
Tandem Diabetes Care (NASDAQ:TNDM) reported record Q2 2026 sales of $255 million, despite a slight miss on revenue forecasts, driven by a strategic transition to a "PayGo" pharmacy-based reimbursement model. This new model is expected to more than double lifetime revenue per patient and …
TNDM
main company
Sharemaestro market context
Price above Trend Line
52 weeks +90.4%
Ametek Inc. stock outperforms competitors despite losses on the day
Ametek Inc. (AME) shares fell by 1.33% to $251.38 on Thursday, ending a five-day winning streak, despite outperforming the broader market. This occurred during a generally negative trading session where the S&P 500 Index dropped 0.18% and the Dow Jones Industrial Average fell 0.85%.
AME
main company
Sharemaestro market context
Trend signal active
52 weeks +37.1% · Next-week setup positive 55.4%
Tandem Diabetes Care, Inc. (TNDM) Reports Q2 Loss, Lags Revenue Estimates
Tandem Diabetes Care, Inc. (TNDM) reported a Q2 loss of $0.31 per share, exceeding the Zacks Consensus Estimate of a $0.34 loss, marking an 8.82% surprise. Despite this, the company's Q2 revenues of $254.56 million missed the consensus estimate by 0.1%, leading to an …
TNDM
main company
Sharemaestro market context
Price above Trend Line
52 weeks +90.4%
Badger Meter’s (BMI) Revenue Contraction Signals Demand Air Pocket
Conestoga Capital Advisors, an asset management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The letter reports a positive market shift towards Small Caps, with the Russell 2000 Index achieving its best first half since 1991 …
BMI
main company
Sharemaestro market context
Price below Trend Line
52 weeks -30.3%
NetEase Cloud Music Inc. to Report First Half 2026 Financial Results on August 20, 2026
NetEase Cloud Music Inc. (HKEX: 9899) announced it will release its financial results for the first half of 2026 on Thursday, August 20, 2026, after the Hong Kong market closes. The company's management will host an earnings conference call on the same day at …
Sharemaestro market context Trend signal active 52 weeks -2.8%